Search

Your search keyword '"Kato, Takuma"' showing total 708 results
Start Over Author "Kato, Takuma"
708 results on '"Kato, Takuma"'

2. Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement

Author

Tanegashima, Tokiyoshi, Shiota, Masaki, Kimura, Takahiro, Takamatsu, Dai, Matsui, Yoshiyuki, Yokomizo, Akira, Saito, Ryoichi, Morizane, Shuichi, Miyake, Makito, Tsutsumi, Masakazu, Yamamoto, Yoshiyuki, Tashiro, Kojiro, Tomida, Ryotaro, Edamura, Kohei, Narita, Shintaro, Yamaguchi, Takahiro, Kasahara, Takashi, Hashimoto, Kohei, Kato, Masashi, Yoshino, Takayuki, Akamatsu, Shusuke, Matsukawa, Akihiro, Kaneko, Tomoyuki, Matsumoto, Ryuji, Joraku, Akira, Kato, Manabu, Saito, Toshihiro, Kato, Takuma, Tatarano, Shuichi, Sakamoto, Shinichi, Kanno, Hidenori, Terada, Naoki, Nishiyama, Naotaka, Kitamura, Hiroshi, and Eto, Masatoshi

Published
2024
Full Text
View/download PDF

3. Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy

Author

Shiota, Masaki, Takamatsu, Dai, Matsui, Yoshiyuki, Yokomizo, Akira, Morizane, Shuichi, Saito, Ryoichi, Miyake, Makito, Tsutsumi, Masakazu, Yamamoto, Yoshiyuki, Tashiro, Kojiro, Tomida, Ryotaro, Narita, Shintaro, Edamura, Kohei, Yamaguchi, Takahiro, Hashimoto, Kohei, Kato, Masashi, Kasahara, Takashi, Yoshino, Takayuki, Akamatsu, Shusuke, Kaneko, Tomoyuki, Matsukawa, Akihiro, Matsumoto, Ryuji, Joraku, Akira, Saito, Toshihiro, Kato, Takuma, Kato, Manabu, Enokida, Hideki, Sakamoto, Shinichi, Terada, Naoki, Kanno, Hidenori, Nishiyama, Naotaka, Kimura, Takahiro, Kitamura, Hiroshi, and Eto, Masatoshi

Published
2024
Full Text
View/download PDF

4. Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study

Author

Taoka, Rikiya, Kamada, Masaki, Izumi, Kazuyoshi, Tanimoto, Ryuta, Daizumoto, Kei, Hayashida, Yushi, Uematsu, Katsutoshi, Arai, Hironobu, Sano, Takeshi, Saito, Ryoichi, Hirama, Hiromi, Kobayashi, Toshihiro, Honda, Tomoko, Osaki, Yu, Abe, Yohei, Naito, Hirohito, Tohi, Yoichiro, Matsuoka, Yuki, Kato, Takuma, Okazoe, Homare, Ueda, Nobufumi, and Sugimoto, Mikio

Published
2024
Full Text
View/download PDF

5. Avatar Fusion Karaoke: Research and development on multi-user music play VR experience in the metaverse

Author

Berthault, Alexandre, Kato, Takuma, and Shirai, Akihiko

Subjects
Computer Science - Human-Computer Interaction, I.2, I.3
Abstract

This paper contributes to building a standard process of research and development (R&D) for new user experiences (UX) in metaverse services. We tested this R&D process on a new UX proof of concept (PoC) for Meta Quest head-mounted display (HMDs) consisting of a school-life karaoke experience with the hypothesis that it is possible to design the avatars with only the necessary functions and rendering costs. The school life metaverse is a relevant subject for discovering issues and problems in this type of simultaneous connection. To qualitatively evaluate the potential of a multi-person metaverse experience, this study investigated subjects where each avatar requires expressive skills. While avatar play experiences feature artistic expressions, such as dancing, playing musical instruments, and drawing, and these can be used to evaluate their operability and expressive capabilities qualitatively, the Quest's tracking capabilities are insufficient for full-body performance and graphical art expression. Considering such hardware limitations, this study evaluated the Quest, focusing primarily on UX simplicity using AI Fusion techniques and expressiveness in instrumental scenes played by approximately four avatars. This research reported methods for multiuser metaverse communication and its supporting technologies, such as head-mounted devices and their graphics performance, special interaction techniques, and complementary tools and the importance of PoC development, its evaluation, and its iterations. The result is remarkable for further research; these expressive technologies in a multi-user context are directly related to the quality of communication within the metaverse and the value of the user-generated content (UGC) produced there., Comment: Accepted in the conference IEEE MetaCom 2023

Published
2023

6. PSA doubling time 4.65 months as an optimal cut-off of Japanese nonmetastatic castration-resistant prostate cancer

Author

Sakamoto, Shinichi, Sato, Kodai, Kimura, Takahiro, Matsui, Yoshiyuki, Shiraishi, Yusuke, Hashimoto, Kohei, Miyake, Hideaki, Narita, Shintaro, Miki, Jun, Matsumoto, Ryuji, Kato, Takuma, Saito, Toshihiro, Tomida, Ryotaro, Shiota, Masaki, Joraku, Akira, Terada, Naoki, Suekane, Shigetaka, Kaneko, Tomoyuki, Tatarano, Shuichi, Yoshio, Yuko, Yoshino, Takayuki, Nishiyama, Naotaka, Kawakami, Eiryo, Ichikawa, Tomohiko, and Kitamura, Hiroshi

Published
2024
Full Text
View/download PDF

7. Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study

Author

Sazuka, Tomokazu, Matsushita, Yuto, Sato, Hiroaki, Osawa, Takahiro, Hinata, Nobuyuki, Hatakeyama, Shingo, Numakura, Kazuyuki, Ueda, Kosuke, Kimura, Takahiro, Takahashi, Masayuki, Tanaka, Hajime, Kawasaki, Yoshihide, Kurahashi, Toshifumi, Kato, Takuma, Fujita, Kazutoshi, Miyake, Makito, Kojima, Takahiro, Kitamura, Hiroshi, Miyake, Hideaki, and Ichikawa, Tomohiko

Published
2023
Full Text
View/download PDF

10. Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study

Author

Tohi, Yoichiro, Ishikawa, Ryou, Kato, Takuma, Miyakawa, Jimpei, Matsumoto, Ryuji, Mori, Keiichiro, Mitsuzuka, Koji, Inokuchi, Junichi, Matsumura, Masafumi, Shiga, Kenichiro, Naito, Hirohito, Kohjimoto, Yasuo, Kawamura, Norihiko, Inoue, Masaharu, Kinoshita, Hidefumi, Hashimoto, Kohei, Goto, Keisuke, Haba, Reiji, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Published
2023
Full Text
View/download PDF

11. Embeddings of Label Components for Sequence Labeling: A Case Study of Fine-grained Named Entity Recognition

Author

Kato, Takuma, Abe, Kaori, Ouchi, Hiroki, Miyawaki, Shumpei, Suzuki, Jun, and Inui, Kentaro

Subjects
Computer Science - Computation and Language
Abstract

In general, the labels used in sequence labeling consist of different types of elements. For example, IOB-format entity labels, such as B-Person and I-Person, can be decomposed into span (B and I) and type information (Person). However, while most sequence labeling models do not consider such label components, the shared components across labels, such as Person, can be beneficial for label prediction. In this work, we propose to integrate label component information as embeddings into models. Through experiments on English and Japanese fine-grained named entity recognition, we demonstrate that the proposed method improves performance, especially for instances with low-frequency labels., Comment: Accepted by ACL SRW 2020

Published
2020

15. Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium

Author

Tohi, Yoichiro, Kato, Takuma, Fukuhara, Hideo, Kobayashi, Keita, Ohira, Shin, Ikeda, Kenichiro, Daizumoto, Kei, Katayama, Satoshi, Shimizu, Ryutaro, Nishimura, Kenichi, Nagami, Taichi, Hayashida, Yushi, Hirama, Hiromi, Takamoto, Atsushi, Dainichi, Teruki, and Sugimoto, Mikio

Published
2022
Full Text
View/download PDF

18. Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN

Author

Kato, Takuma, Hirama, Hiromi, Mitsuzuka, Koji, Maruyama, Satoru, Sasaki, Hiroshi, Saito, Toshihiro, Matsumoto, Ryuji, Sakamoto, Shinichi, Sakai, Yasuyuki, Fukuhara, Hiroshi, Naya, Yukio, Tsukino, Hiromasa, Hara, Isao, Ogawa, Osamu, Hashine, Katsuyoshi, Fumimasa, Fukuta, Yokomizo, Akira, Tohi, Yoichiro, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Published
2022
Full Text
View/download PDF

20. Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)—a prospective single-arm interventional study

Author

Sugimoto, Mikio, Kato, Takuma, Tohi, Yoichiro, Shimizu, Yosuke, Matsumoto, Ryuji, Inoue, Takahiro, Takezawa, Yutaka, Masui, Kimihiko, Sasaki, Hiroshi, Hirama, Hiromi, Saito, Shiro, Egawa, Shin, Kamoto, Toshiyuki, Teramukai, Satoshi, Kojima, Shinsuke, Kikuchi, Takashi, and Kakehi, Yoshiyuki

Published
2022
Full Text
View/download PDF

21. Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS‐JAPAN).

Author

Kato, Takuma, Matsumoto, Ryuji, Yokomizo, Akira, Tohi, Yoichiro, Fukuhara, Hiroshi, Fujii, Yoichi, Mori, Keiichiro, Sato, Takuma, Inokuchi, Junichi, Hashine, Katsuyoshi, Sakamoto, Shinichi, Kinoshita, Hidefumi, Inoue, Koji, Tanikawa, Toshiki, Utsumi, Takanobu, Goto, Takayuki, Hara, Isao, Okuno, Hiroshi, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Subjects
*TUMOR antigens, *PROSTATE cancer patients, *MAGNETIC resonance imaging, *WATCHFUL waiting, *JAPANESE people
Abstract

Objective: To report the outcomes of repeat biopsies, metastasis and survival in the Prostate Cancer Research International: Active Surveillance (PRIAS)‐JAPAN study, a prospective observational study for Japanese patients, initiated in 2010. Patients and Methods: At the beginning, inclusion criteria were initially low‐risk patients, prostate‐specific antigen (PSA) density (PSAD) <0.2, and ≤2 positive biopsy cores. As from 2014, GS3+4 has also been allowed for patients aged 70 years and over. Since January 2021, the age limit for Gleason score (GS) 3 + 4 cases was removed, and eligibility criteria were expanded to PSA ≤20 ng/mL, PSAD <0.25 nd/mL/cc, unlimited number of positive GS 3 + 3 cores, and positive results for fewer than half of the total number of cores for GS 3 + 4 cases if magnetic resonance imaging fusion biopsy was performed at study enrolment or subsequent follow‐up. For patients eligible for active surveillance, PSA tests were performed every 3 months, rectal examination every 6 months, and biopsies at 1, 4, 7 and 10 years, followed by every 5 years thereafter. Patients with confirmed pathological reclassification were recommended for secondary treatments. Results: As of February 2024, 1302 patients were enrolled in AS; 1274 (98%) met the eligibility criteria. The median (interquartile range) age, PSA level, PSAD, and number of positive cores were 69 (64–73) years, 5.3 (4.5–6.6) ng/mL, 0.15 (0.12–0.17) ng/mL, and 1 (1–2), respectively. The clinical stage was T1c in 1089 patients (86%) and T2 in 185 (15%). The rates of acceptance by patients for the first, second, third and fourth re‐biopsies were 83%, 64%, 41% and 22%, respectively. The pathological reclassification rates for the first, second, third and fourth re‐biopsies were 29%, 30%, 35% and 25%, respectively. The 1‐, 5‐ and 10‐year persistence rates were 77%, 45% and 23%, respectively. Six patients developed metastasis, and one patient died from prostate cancer. Conclusion: Pathological reclassification was observed in approximately 30% of the patients during biopsy; however, biopsy acceptance rates decreased over time. Although metastasis occurred in six patients, only one death from prostate cancer was recorded. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

22. Conformational Analysis and Organocatalytic Activity of Helical Stapled Peptides Containing α-Carbocyclic α,α-Disubstituted α-Amino Acids.

Author

Iyoshi, Akihiro, Ueda, Atsushi, Umeno, Tomohiro, Kato, Takuma, Hirayama, Kazuhiro, Doi, Mitsunobu, and Tanaka, Masakazu

Subjects
NUCLEOPHILIC reactions, PEPTIDES, CATALYTIC activity, EPOXIDATION, STEREOSELECTIVE reactions
Abstract

Conformational freedom-restricted peptides, such as stapled peptides, play a crucial role in the advancement of functional peptide development. We synthesized stapled octapeptides using α-carbocyclic α,α-disubstituted α-amino acids, particularly 3-allyloxy-1-aminocyclopentane-1-carboxylic acid, as the crosslink motifs. The organocatalytic capabilities of the synthesized stapled peptides were assessed in an asymmetric nucleophilic epoxidation reaction because the catalytic activities are known to be proportional to α-helicity. Despite incorporating side-chain crosslinks, the enantioselectivities of the epoxidation reaction catalyzed by stapled octapeptides were found to be comparable to those obtained using unstapled peptides. Interestingly, the stapled peptides using α-carbocyclic α,α-disubstituted α-amino acids demonstrated higher reactivities and stereoselectivities (up to 99% ee) compared to stapled peptides derived from (S)-α-(4-pentenyl)alanine, a commonly used motif for stapled peptides. These differences could be attributed to the increased α-helicity of the former stapled peptide in contrast to the latter, as evidenced by the X-ray crystallographic structures of their N-tert-butoxycarbonyl derivatives. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Impact of the coronavirus disease pandemic on robot‐assisted radical prostatectomy and urologists' treatment behaviors: A single tertiary center retrospective study.

Author

Tohi, Yoichiro, Osaki, Yu, Kato, Takuma, Honda, Tomoko, Abe, Yohei, Naito, Hirohito, Matsuoka, Yuki, Okazoe, Homare, Taoka, Rikiya, Ueda, Nobufumi, and Sugimoto, Mikio

Subjects
ANDROGEN deprivation therapy, COVID-19, RADICAL prostatectomy, COVID-19 pandemic, UROLOGISTS, PROSTATE cancer
Abstract

Objectives: To assess whether the coronavirus disease (COVID‐19) pandemic affected the outcomes of robot‐assisted radical prostatectomy (RARP) and urologists' treatment behaviors. Methods: We retrospectively examined the medical records of 208 patients who had undergone RARP between August 2017 and December 2022. We compared the rate of preoperative androgen deprivation therapy (ADT), waiting period for RARP, patients' baseline characteristics and quality of life (QOL), proportion of adverse pathology on the RARP specimen, rate of Gleason grade group upgrading from biopsy to the RARP specimen, and prostate‐specific antigen (PSA) recurrence‐free survival between the pre‐pandemic and pandemic groups. Results: The rate of preoperative ADT was significantly higher during than before the COVID‐19 pandemic (13.7% vs. 1.9%; p = 0.002). The baseline physical and mental QOL scores did not differ significantly between the groups. The proportion of D'Amico low‐risk patients was significantly lower (13.6% vs. 1.2%, p = 0.005) and waiting period for RARP was significantly shorter (median 3.5 months vs. 4.0 months, p = 0.016) in the pandemic group than in the pre‐pandemic group. There was no significant difference in the proportion of adverse pathology between the groups (p = 0.104); however, the upgrading rate was significantly higher in the pre‐pandemic group (p = 0.002). There was no significant difference in PSA recurrence‐free survival between the groups (log‐rank, p = 0.752). Conclusions: The COVID‐19 pandemic did not adversely affect the oncologic outcomes of RARP and QOL before RARP. However, it caused urologists to increase the use of preoperative ADT and to reserve RARP for higher‐risk cases. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study

Author

Tohi, Yoichiro, Kato, Takuma, Nakamura, Masaki, Matsumoto, Ryuji, Sasaki, Hiroshi, Mitsuzuka, Koji, Inokuchi, Junichi, Hashine, Katsuyoshi, Yokomizo, Akira, Naito, Hirohito, Hara, Isao, Kawamura, Norihiko, Inoue, Masaharu, Fukuhara, Hiroshi, Maruyama, Satoru, Sakamoto, Shinichi, Saito, Toshihiro, Egawa, Shin, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Published
2022
Full Text
View/download PDF

28. Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN

Author

Hirama, Hiromi, Sugimoto, Mikio, Miyatake, Nobuyuki, Kato, Takuma, Venderbos, Lionne D. F., Remmers, Sebastiaan, Shiga, Kenichiro, Yokomizo, Akira, Mitsuzuka, Koji, Matsumoto, Ryuji, Osawa, Takahiro, Abe, Takashige, Sasaki, Hiroshi, Egawa, Shin, Ninomiya, Iku, Hashine, Katsuyoshi, Roobol, Monique J., and Kakehi, Yoshiyuki

Published
2021
Full Text
View/download PDF

36. The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study

Author

Tohi, Yoichiro, Kato, Takuma, Matsumoto, Ryuji, Shinohara, Nobuo, Shiga, Kenichiro, Yokomizo, Akira, Nakamura, Masaki, Kume, Haruki, Mitsuzuka, Koji, Sasaki, Hiroshi, Egawa, Shin, Matsumura, Masafumi, Hashine, Katsuyoshi, Inokuchi, Junichi, Eto, Masatoshi, Baba, Haruki, Ichikawa, Tomohiko, Kinoshita, Hidefumi, Matsuda, Tadashi, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Published
2020
Full Text
View/download PDF

37. How widespread is active surveillance of early‐stage prostate cancer in Japan? Multicenter questionnaire survey on the status of active surveillance of early‐stage prostate cancer in Japan.

Author

Kato, Takuma, Tohi, Yoichiro, Okazoe, Homare, Taoka, Rikiya, Ueda, Nobufumi, and Sugimoto, Mikio

Subjects
*MEDICAL personnel, *WATCHFUL waiting, *PROSTATE cancer patients, *MEDICAL care costs, *PATIENT education, *PROSTATE cancer
Abstract

This article discusses the prevalence of active surveillance (AS) for early-stage prostate cancer in Japan. A survey was conducted among cancer treatment facilities to assess the status of AS implementation. The results showed that the proportion of patients receiving AS was 10%, which is similar to the findings of a previous national survey in 2010. However, compared to Western countries, the use of AS in Japan is limited, indicating potential overdiagnosis and overtreatment of early-stage prostate cancer. The study suggests that patient education and physician support are needed to promote AS in Japan. [Extracted from the article]

Published
2024
Full Text
View/download PDF

39. Association of initial adjustment dose of apalutamide with progression to castration-resistant prostate cancer and skin-adverse events in men with metastatic castration-sensitive prostate cancer: A multicenter retrospective study of CsJUC cohort.

Author

Tohi, Yoichiro, Kato, Takuma, Kobayashi, Keita, Daizumoto, Kei, Fukuhara, Hideo, Ohira, Shin, Katayama, Satoshi, Shimizu, Ryutaro, Takamoto, Atsushi, Nishimura, Kenichi, Ikeda, Kenichiro, Nagami, Taichi, and Sugimoto, Mikio

Published
2024
Full Text
View/download PDF

40. Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium

Author

Tohi, Yoichiro, Kato, Takuma, Kobayashi, Keita, Daizumoto, Kei, Fukuhara, Hideo, Ohira, Shin, Katayama, Satoshi, Shimizu, Ryutaro, Takamoto, Atsushi, Nishimura, Kenichi, Ikeda, Kenichiro, Nagami, Taichi, Hayashida, Yushi, Hirama, Hiromi, Naito, Hirohito, Tomida, Ryotaro, Sasaki, Yutaro, Yamamoto, Shinkuro, Shimizu, Shinjiro, and Sugimoto, Mikio

Published
2024
Full Text
View/download PDF

42. Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model

Author

Takeuchi, Yuta, primary, Wang, Yizheng, additional, Sasaki, Katsunori, additional, Sato, Osamu, additional, Tsuchikawa, Takahiro, additional, Wang, Linan, additional, Amaishi, Yasunori, additional, Okamoto, Sachiko, additional, Mineno, Junichi, additional, Hirokawa, Yoshifumi, additional, Hatanaka, Kanako C., additional, Hatanaka, Yutaka, additional, Kato, Takuma, additional, Shiku, Hiroshi, additional, and Hirano, Satoshi, additional

Published
2023
Full Text
View/download PDF

44. Advancing the partnership between Japan and Thailand on global health and UHC: 'new normal' approach during COVID-19 pandemic

Author

Miyashita, Yumiko, Kato, Takuma, Panichkriangkrai, Warisa, Wisasa, Wialiluk, and Patcharanarumol, Walaiporn

Subjects
Policy Forum, General Medicine
Abstract

Partnerships, particularly, South-South and Triangular Cooperation play an important role in the 2030 Agenda for Sustainable Development. The Partnership Project for Global Health and Universal Health Coverage (UHC) between Japan and Thailand (the Project) was launched in 2016 as a four-year flagship project for Triangular Cooperation and continued to the second phase in 2020. Participating countries include Asian and African countries who are striving to drive global health and to move towards UHC. However, the COVID-19 pandemic has made coordination of partnerships more difficult. The Project needed to find a "new normal" approach to conduct our collaborative work. Struggling with public health and social measures for COVID-19 has made us more resilient and has increased opportunities to collaborate more closely. In the past year and a half, during the COVID-19 pandemic, the Project successfully conducted a number of online activities between Thailand and Japan and with other countries on global health and UHC. Our "new normal" approach led continuing dialogue of networking both at the project implementation and policy levels, focusing on desk-based activities regarding the targets and the objectives of the project and creating a golden opportunity for pursuing a timely second phase. Our lessons learned include as follows: i) Closer prior consultation is required to hold satisfactory online meetings; ii) Effective "new normal" approaches include emphasizing practical and interactive discussions on each countrys priority issues and expanding target participants; iii) Commitment, trust, teamwork, and sharing common goals can enhance and sustain partnerships, especially amid the pandemic.

Published
2023

47. Correction to: The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study

Author

Tohi, Yoichiro, Kato, Takuma, Matsumoto, Ryuji, Shinohara, Nobuo, Shiga, Kenichiro, Yokomizo, Akira, Nakamura, Masaki, Kume, Haruki, Mitsuzuka, Koji, Sasaki, Hiroshi, Egawa, Shin, Matsumura, Masafumi, Hashine, Katsuyoshi, Inokuchi, Junichi, Eto, Masatoshi, Baba, Haruki, Ichikawa, Tomohiko, Kinoshita, Hidefumi, Matsuda, Tadashi, Kakehi, Yoshiyuki, and Sugimoto, Mikio

Published
2022
Full Text
View/download PDF

50. CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy

Author

Wang, Yizheng, primary, Wang, Linan, additional, Seo, Naohiro, additional, Okumura, Satoshi, additional, Hayashi, Tae, additional, Akahori, Yasushi, additional, Fujiwara, Hiroshi, additional, Amaishi, Yasunori, additional, Okamoto, Sachiko, additional, Mineno, Junichi, additional, Tanaka, Yoshimasa, additional, Kato, Takuma, additional, and Shiku, Hiroshi, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results